Angiogenesis

Angiogenesis is the formation and remodelling of new blood vessels and capillaries from growth of pre-existing blood vessels. It normally occurs during wound healing and embryonic development, but is also required for tumour growth and metastasis in cancer.

5 个项目

每页

设置降序顺序
  1. Tandutinib (MLN518)

    Catalog No. A10887
    Quick View
    FLT3 抑制剂
    Tandutinib (MLN518)是一种有效的FLT3抑制剂,c-KIT和PDGF受体酪氨酸激酶的自磷酸化,从而抑制细胞增殖并诱导细胞凋亡。 了解更多
  2. Pexidartinib (PLX3397)

    Catalog No. A15520
    Quick View
    CSF1/Kit/FLT3 抑制剂
    Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。 了解更多
  3. Dovitinib Dilactic acid (TKI258 Dilactic acid)

    Catalog No. A10198
    Quick View
    RTK 抑制剂
    Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。 了解更多
  4. Dovitinib (TKI-258)

    Catalog No. A11411
    Quick View
    RTK 抑制剂
    Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。 了解更多
  5. Pazopanib (GW-786034)

    Catalog No. A11518
    Quick View
    VEGFR 抑制剂
    Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻止肿瘤生长并抑制血管生成。 了解更多

5 个项目

每页

设置降序顺序
Rewards